Top Markets
Coin of the day
Upstream Bio, Inc. Upstream Bio, Inc.

Upstream Bio, Inc.

UPB
Rangering i aksjer #15297
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Aksjekurs
$6.57
Markedsverdi
$357.27M
Endring (1 dag)
-0.83%
Endring (1 år)
-61.68%
Land
US
Handel Upstream Bio, Inc. (UPB)

Kategori

P/S-forhold for Upstream Bio, Inc. (UPB)
P/S-forhold per 2026 TTM: 0
Ifølge Upstream Bio, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Upstream Bio, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
10.95 -
US
12.19 -
NL
3.75 -
AU
24.99 -
US
- -
CH